PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2020277
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2020277
The global airway management devices market was valued at USD 2.13 billion in 2025 and is projected to grow to USD 2.23 billion in 2026, reaching USD 3.25 billion by 2034, reflecting a CAGR of 4.85% during the forecast period (2026-2034). North America dominated the market with a 47.1% share in 2025, driven by high R&D investments and the launch of advanced airway management technologies.
Airway management devices, including bag-valve masks, endotracheal tubes, and laryngoscopes, play a critical role in providing ventilation and restoring breathing in patients with airway obstruction. The rising prevalence of chronic conditions such as COPD, cancer, and chronic lung diseases has significantly contributed to the demand for these devices. According to the National Center for Biotechnology Information (NCBI, 2022), the global prevalence of COPD among people aged 40 and above is around 10.1%, while the American Lung Association (2020) reported that 12.5 million U.S. adults (5% of the population) were diagnosed with COPD, chronic bronchitis, or emphysema, with 148,512 deaths recorded due to COPD.
The increase in chronic disease prevalence has also amplified emergency and intensive care admissions globally. In the U.S., CDC data (2022) shows 16.2 million emergency department visits resulted in hospital admissions, with 2.3 million requiring critical care. This surge in emergency and inpatient care, coupled with rising surgical procedures and anesthetic interventions, has driven the adoption of airway management devices.
Market Trends
The adoption of airway management devices is particularly increasing among neonates, due to the rise in premature births. The WHO (2023) reported approximately 13.4 million premature births worldwide in 2020, representing more than 10% of all births. In the U.S., CDC (2022) data indicates 1 in 10 births is preterm, with a 4% increase in preterm birth rate from 2020 to 2021. Premature infants frequently experience breathing disorders, increasing the need for airway management. Advanced pediatric devices, such as Medtronic's SonarMed system, allow real-time monitoring of endotracheal tube positioning, reducing complications like unplanned extubations and improving outcomes.
Market Growth Factors
The market is further bolstered by joint ventures, start-ups, and R&D investments by key industry players. Companies like Medtronic, ICU Medical, and Teleflex Incorporated are expanding production capabilities and launching innovative devices. For example, ICU Medical's acquisition of Smiths Medical in 2022 expanded its portfolio in airway management and infusion devices, while LifeMech's A-VS resuscitator received FDA approval in 2020, supporting emergency respiratory care during COVID-19. These investments in technologically advanced devices are anticipated to propel market growth across emerging nations.
Market Restraints
Despite growing demand, complications associated with device use can limit adoption. Intubation and airway devices carry risks such as regurgitation, aspiration, vascular compression, trauma, and nerve injury. According to NCBI (2021), tracheostomy bleeding occurs in 0.6-5% of cases globally, and NCBI (2023) reports cardiovascular instability, hypoxemia, and cardiac arrest rates of 42.6%, 9.3%, and 3.1%, respectively, linked to airway devices. Pediatric laryngeal masks may also cause soft-tissue trauma, vomiting, and airway restriction, highlighting the need for cautious usage.
Market Segmentation
By Type:
By Application:
By End-User:
Key Companies & Developments
Prominent players include Medtronic (Ireland), Teleflex Incorporated (U.S.), KARL STORZ (Germany), ICU Medical (U.S.), Convatec (U.K.), Ambu A/S (Denmark), and Intersurgical Ltd (U.K.). Recent developments include:
Conclusion
The global airway management devices market is poised for steady growth, driven by rising chronic respiratory disorders, increasing surgical and emergency procedures, technological advancements, and expanding applications in neonatal care. While complications associated with device usage remain a restraint, strategic investments, product innovations, and regional expansion efforts by key players are expected to propel the market to USD 3.25 billion by 2034.
Segmentation By Type
By Application
By End User
By Region